Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Exelixis (EXEL) and Techne (TECH). But which of these two stocks is more attractive to value ...

In a report released today, Asthika Goonewardene from Truist Financial maintained a Buy rating on Exelixis (EXEL – Research Report). The company’s shares closed yesterday at $37.20.

Exel Solar and JA Solar signed the module supply agreement at the RE+ Mexico event this year. Image: PRNewsFoto and JA Solar. Leading Chinese module manufacturer JA Solar has signed a module ...

Julie Smith, a director at $EXEL, sold 19,294 shares of the company on 02-28-2025 for an estimated $725,840. We received data on the trade from a recent SEC filing ...

Selecting the right version of Microsoft Excel is a critical decision that can influence your productivity, collaboration, and overall user experience. With multiple options available, including ...

Exelixis (EXEL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. Over the last 7 days, the United States market has experienced a 2.5% ...

Explore Exelixis stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for EXEL. Exelixis reaffirmed its 2025 sales guidance of $2.15-$2.25 billion and reported ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Exelixis (EXEL) came out with quarterly earnings of $0.55 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.33 per share a year ago. These figures ...

$EXEL insiders have traded $EXEL stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.